Europe Cellulite Treatment Market Forecast 2023-2032

The Europe cellulite treatment market is expected to grow with a CAGR of 9.47% during the forecasting period of 2023-2032. The regional market's growth is fueled by the surge in the occurrence of obesity, coupled with the rise in the aging population, the increasing adoption of advanced technologies as well as the launch of new products, and the growing inclination towards minimally invasive and non-invasive procedures.

MARKET INSIGHTS

The Europe cellulite treatment market growth assessment entails the evaluation of France, Italy, Belgium, Germany, the United Kingdom, Poland, and Rest of Europe. The high fashion, as well as aesthetic consciousness in France, is anticipated to fuel the demand for cellulite treatments over the upcoming years. Moreover, the surging availability of plastic surgeons as well as the growing beauty consciousness in the country, is set to further fuel the number of cellulite treatment procedures, thus contributing to market growth.

According to the data issued by the Organization for Economic Cooperation and Development (OECD), while around 1 in 10 people in France are obese, nearly 40% are overweight. Additionally, as per World Bank data, approximately 21% of the country's population was aged 65 years and over. Since excess weight leads to cellulite and obesity increases with age, the surging incidence of obesity is further expected to drive the need for cellulite treatments in France. As a result, these factors are projected to play an essential role in propelling market growth in Europe during the forecast period.

COMPETITIVE INSIGHTS

Major companies operating in the market are: Zimmer MedizinSysteme, Inceler Medikal Co Ltd, Sinclair Pharma, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 50823

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
- 2.5.1. RISING BEAUTY CONSCIOUSNESS
- 2.5.2. GROWING PREFERENCE TOWARDS NON-INVASIVE PROCEDURES
- 2.5.3. RAPID TECHNOLOGICAL ADVANCEMENTS TO PROMOTE MARKET GROWTH
- 2.5.4. RAPIDLY CHANGING LIFESTYLES LEADING TO OBESITY

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. GROWING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES
- 3.1.2. RISING CASES OF OBESITY
- 3.1.3. RAPIDLY BOOMING MEDICAL TOURISM INDUSTRY
3.2. KEY RESTRAINTS
- 3.2.1. HIGH COST OF ADVANCED CELLULITE TREATMENT
- 3.2.2. SIDE EFFECTS POST-TREATMENT
- 3.2.3. LACK OF AWARENESS

4. KEY ANALYTICS

4.1. PARENT MARKET ANALYSIS
4.2. KEY TECHNOLOGY TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. VALUE CHAIN ANALYSIS
- 4.7.1. RESEARCH AND DEVELOPMENT
- 4.7.2. PRODUCT DEVELOPMENT
- 4.7.3. MARKETING AND DISTRIBUTION
- 4.7.4. POST-SALES MONITORING
4.8. KEY BUYING CRITERIA
- 4.8.1. COST
- 4.8.2. BRAND REPUTATION
- 4.8.3. USABILITY

5. MARKET BY PROCEDURE

5.1. NON-INVASIVE
5.2. MINIMALLY INVASIVE
5.3. TOPICAL

6. MARKET BY TYPE

6.1. SOFT CELLULITE
6.2. HARD CELLULITE
6.3. EDEMATOUS CELLULITE

7. MARKET BY END-USER

7.1. HOSPITALS
7.2. CLINICS AND BEAUTY CENTERS
7.3. OTHER END-USERS

8. GEOGRAPHICAL ANALYSIS

8.1. EUROPE
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. EUROPE CELLULITE TREATMENT MARKET DRIVERS
- 8.1.3. EUROPE CELLULITE TREATMENT MARKET CHALLENGES
- 8.1.4. EUROPE CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
- 8.1.5. KEY PLAYERS IN EUROPE CELLULITE TREATMENT MARKET
- 8.1.6. COUNTRY ANALYSIS
  - 8.1.6.1. UNITED KINGDOM
  - 8.1.6.1.1. UNITED KINGDOM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.1.6.2. GERMANY
  - 8.1.6.2.1. GERMANY CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.1.6.3. FRANCE
  - 8.1.6.3.1. FRANCE CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.1.6.4. ITALY
  - 8.1.6.4.1. ITALY CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.1.6.5. BELGIUM
  - 8.1.6.5.1. BELGIUM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.1.6.6. POLAND
  - 8.1.6.6.1. POLAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.1.6.7. REST OF EUROPE
  - 8.1.6.7.1. REST OF EUROPE CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
- 9.2.1. ABBVIE INC
  - 9.2.1.1. COMPANY OVERVIEW
  - 9.2.1.2. FINANCIAL ANALYSIS
  - 9.2.1.3. PRODUCTS / SERVICES LIST
  - 9.2.1.4. STRENGTHS & CHALLENGES
- 9.2.2. ALMA LASERS
  - 9.2.2.1. COMPANY OVERVIEW
  - 9.2.2.2. PRODUCTS / SERVICES LIST
- 9.2.3. BAUSCH HEALTH COMPANIES INC.
  - 9.2.3.1. COMPANY OVERVIEW
  - 9.2.3.2. FINANCIAL ANALYSIS
  - 9.2.3.3. PRODUCTS / SERVICES LIST
  - 9.2.3.4. STRENGTHS & CHALLENGES
- 9.2.4. CANDELA CORPORATION
  - 9.2.4.1. COMPANY OVERVIEW
  - 9.2.4.2. PRODUCTS / SERVICES LIST
  - 9.2.4.3. STRENGTHS & CHALLENGES
- 9.2.5. CUTERA INC
  - 9.2.5.1. COMPANY OVERVIEW
  - 9.2.5.2. FINANCIAL ANALYSIS
  - 9.2.5.3. PRODUCTS / SERVICES LIST
  - 9.2.5.4. STRENGTHS & CHALLENGES
- 9.2.6. CYNOSURE LLC
  - 9.2.6.1. COMPANY OVERVIEW
  - 9.2.6.2. PRODUCTS / SERVICES LIST
  - 9.2.6.3. STRENGTHS & CHALLENGES
- 9.2.7. ENDO INTERNATIONAL PLC
  - 9.2.7.1. COMPANY OVERVIEW
  - 9.2.7.2. FINANCIAL ANALYSIS
  - 9.2.7.3. PRODUCTS / SERVICES LIST
  - 9.2.7.4. STRENGTHS & CHALLENGES
- 9.2.8. GALDERMA SA
  - 9.2.8.1. COMPANY OVERVIEW
  - 9.2.8.2. PRODUCTS / SERVICES LIST
  - 9.2.8.3. STRENGTHS & CHALLENGES
- 9.2.9. INCELER MEDIKAL CO LTD
  - 9.2.9.1. COMPANY OVERVIEW
  - 9.2.9.2. PRODUCTS / SERVICES LIST
  - 9.2.9.3. STRENGTHS & CHALLENGES
- 9.2.10. JOHNSON & JOHNSON
  - 9.2.10.1. COMPANY OVERVIEW
  - 9.2.10.2. FINANCIAL ANALYSIS
  - 9.2.10.3. PRODUCTS / SERVICES LIST
  - 9.2.10.4. STRENGTHS & CHALLENGES
- 9.2.11. MERZ PHARMA GMBH & CO KGAA
  - 9.2.11.1. COMPANY OVERVIEW
  - 9.2.11.2. PRODUCTS / SERVICES LIST
  - 9.2.11.3. STRENGTHS & CHALLENGES
- 9.2.12. NUBWAY CO LTD
  - 9.2.12.1. COMPANY OVERVIEW
  - 9.2.12.2. PRODUCTS / SERVICES LIST
- 9.2.13. SIENTRA INC
  - 9.2.13.1. COMPANY OVERVIEW
  - 9.2.13.2. FINANCIAL ANALYSIS
  - 9.2.13.3. PRODUCTS / SERVICES LIST
  - 9.2.13.4. STRENGTHS & CHALLENGES
- 9.2.14. SINCLAIR PHARMA
  - 9.2.14.1. COMPANY OVERVIEW
  - 9.2.14.2. PRODUCTS / SERVICES LIST
- 9.2.15. ZIMMER MEDIZINSYSTEME
  - 9.2.15.1. COMPANY OVERVIEW
  - 9.2.15.2. PRODUCTS / SERVICES LIST
  - 9.2.15.3. STRENGTHS & CHALLENGES

Product Code: 50823

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - CELLULITE TREATMENT
TABLE 2: EUROPE CELLULITE TREATMENT MARKET, BY PROCEDURE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: EUROPE CELLULITE TREATMENT MARKET, BY PROCEDURE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: EUROPE CELLULITE TREATMENT MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: EUROPE CELLULITE TREATMENT MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: EUROPE CELLULITE TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: EUROPE CELLULITE TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: EUROPE CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
TABLE 11: LEADING PLAYERS OPERATING IN EUROPE CELLULITE TREATMENT MARKET
TABLE 12: LIST OF ACQUISITIONS
TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 15: LIST OF EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY TECHNOLOGY TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: KEY BUYING CRITERIA
FIGURE 8: EUROPE CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY PROCEDURE, IN 2022
FIGURE 9: EUROPE CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2032 (IN $ MILLION)
FIGURE 10: EUROPE CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2032 (IN $ MILLION)
FIGURE 11: EUROPE CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2032 (IN $ MILLION)
FIGURE 12: EUROPE CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022
FIGURE 13: EUROPE CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 14: EUROPE CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 15: EUROPE CELLULITE TREATMENT MARKET, BY EDEMATOUS CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 16: EUROPE CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022
FIGURE 17: EUROPE CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2032 (IN $ MILLION)
FIGURE 18: EUROPE CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2032 (IN $ MILLION)
FIGURE 19: EUROPE CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2032 (IN $ MILLION)
FIGURE 20: EUROPE CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 21: UNITED KINGDOM CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 22: GERMANY CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 23: FRANCE CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 24: ITALY CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 25: BELGIUM CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 26: POLAND CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 27: REST OF EUROPE CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 28: ABBVIE INC COMPANY PROFIT 2017 - 2021 ($ BILLION)
FIGURE 29: ABBVIE INC COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 30: ABBVIE INC COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
FIGURE 31: BAUSCH HEALTH COMPANIES INC COMPANY PROFIT 2017 - 2021 ($ BILLION)
FIGURE 32: BAUSCH HEALTH COMPANIES INC COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 33: BAUSCH HEALTH COMPANIES INC COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
FIGURE 34: CUTERA INC COMPANY PROFIT 2017 - 2021 ($ MILLION)
FIGURE 35: CUTERA INC COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 36: CUTERA INC COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
FIGURE 37: ENDO INTERNATIONAL PLC COMPANY PROFIT 2018 - 2021 ($ MILLION)
FIGURE 38: ENDO INTERNATIONAL PLC COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 39: ENDO INTERNATIONAL PLC COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
FIGURE 40: JOHNSON & JOHNSON COMPANY PROFIT 2017 - 2021 ($ BILLION)
FIGURE 41: JOHNSON & JOHNSON COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 42: JOHNSON & JOHNSON COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
FIGURE 43: JOHNSON & JOHNSON COMPANY REVENUE 2017 - 2021 ($ BILLION)
FIGURE 44: SIENTRA INC COMPANY PROFIT 2017 - 2021 ($ MILLION)